On one hand SLC2A9 mutations are associated with hypouricemia and hyperuricosuria, while on the other, mutations in SLC2A9 that alter the protein impair urate secretion into the urine resulting in hyperuricemia (Le et al., 2008; Cheeseman, 2009). This evidence concerns the gene SLC2A9 and hyperuricemia.